Enimmune Market Cap

Enimmune has a market cap or net worth of 1.37 billion as of April 29, 2026. Its market cap has decreased by -25.39% in one year.

Market Cap

1.37B

Enterprise Value

1.31B

Revenue

48.19M

Ranking

n/a

PE Ratio

n/a

Stock Price

18.70

Market Cap Chart

Since September 18, 2018, Enimmune's market cap has increased from 1.33B to 1.37B, an increase of 2.90%. That is a compound annual growth rate of 0.38%.

Market Cap History

Date	Market Cap	% Change
Apr 29, 2026	1.37B	-8.01%
Dec 31, 2025	1.49B	-17.27%
Dec 31, 2024	1.80B	-27.21%
Dec 29, 2023	2.47B	-38.63%
Dec 30, 2022	4.02B	69.85%
Dec 30, 2021	2.37B	-11.74%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 26, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Abnova (Taiwan)	1.35B
Meribank Biotech	1.34B
NeoCore Technology	1.41B
GenMont Biotech Incorporation	1.54B
BiOptic	1.21B
Advagene Biopharma	1.54B
LabTurbo Biotech	1.15B
GeneReach Biotechnology	1.13B

Market Cap Rankings